scorecardresearch
Friday, March 29, 2024
TopicCentral Drugs Standard Control Organization

Topic: Central Drugs Standard Control Organization

Govt begins internal review of Pfizer and Serum Covid vaccines, focus on safety & quality

The recommendations on granting of authorisation will be made on three parameters — safety, quality and efficacy. The Drug Controller General of India will take the final decision.

Hand sanitiser makers under govt scanner after complaints of ‘substandard’ products

Govt has collected samples of all kinds of hand sanitisers — from local products to top selling brands such as Dettol, Himalaya, Godrej, Savlon — for quality check.

India could be producing over 20,000 vials of Remdesivir per day by month-end: Govt data

Remdesivir is now being manufactured by Cipla, Hetero Labs and Mylan. Cipla Wednesday launched the drug under the brand name Cipremi.

After complaint, Modi govt asks states to keep vigil to stop ‘black-marketing’ of remdesivir

The order comes after the govt received a complaint from LocalCircles, saying the drug, whose MRP is Rs 5,400, is being sold at a price of between Rs 15,000 and Rs 60,000. 

Hetero Labs in Hyderabad seeks nod from govt to market remdesivir, a potential Covid drug

Hetero Labs filed an application with the Central Drugs Standard Control Organisation (CDSCO) last week. The CDSCO may soon reach out to ICMR for suggestions.

Himachal govt to file FIR against cough syrup makers ‘responsible’ for 10 infant deaths 

The Coldbest-PC cough syrup, manufactured by the Himachal-based Digital Vision firm, has allegedly led to deaths of 9 infants in J&K and one in Haryana. 

US approves first medicine for treatment of ‘rare’ thyroid eye disease

The medicine approved by US Food and Drug Administration is called Tepezza, which is manufactured by Irish drugmaker Horizon Therapeutics. 

US flags two top neurological drugs used in India, warns of serious breathing difficulties

US Food and Drug Administration says gabapentin and pregabalin drugs, sold in India to treat neurological disorders, may also harm nervous system.

Explained: Why India, US haven’t recalled acidity drug Ranitidine but France & Canada have

US expert who flagged the presence of cancer-causing NDMA in Ranitidine says sales must stop permanently.

Popular acidity drug has cancer-causing substance, says US health regulator

The drug, Ranitidine, is available in India under the brand names of ‘Aciloc’ and ‘Zinetac’.

On Camera

Profit margins in lottery industry are tiny. Here’s how Future Gaming paid for its electoral bonds

Neither state govts nor companies earn large profits from lotteries. However, a look at the system shows there’s ample evidence of murky dealings and financial irregularities. 

Amid plans to lift AFSPA, Army starts joint training with Jammu & Kashmir Police

In an interview with Gulistan News this week, Union Home Minister Amit Shah said the government would leave law and order to J&K Police and slowly withdraw troops.

For BJP, Kejriwal is an idea whose time has come to be destroyed

The ‘idea’ Kejriwal's politics grew around was a no-holds-barred fight against corruption. That is the reason Modi govt has now tarred him and his entire party with the same paint.